Skip to main content
NOVOGENE CO., LTD. logo

NOVOGENE CO., LTD. — Investor Relations & Filings

Ticker · 688315 ISIN · CNE1000052X3 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 558 across all filing types
Latest filing 2021-04-26 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688315

About NOVOGENE CO., LTD.

https://www.novogene.com

Novogene Co., Ltd. is a global provider of genomic services and solutions, specializing in next-generation sequencing (NGS) and bioinformatics analysis. The company offers a comprehensive suite of services, including whole genome sequencing, transcriptomics, epigenomics, and metagenomics, alongside specialized solutions for single-cell analysis and clinical diagnostics. Utilizing advanced high-throughput sequencing platforms and proprietary bioinformatics pipelines, Novogene supports research across diverse fields such as human health, agriculture, and environmental science. The organization serves a broad client base encompassing academic institutions, pharmaceutical companies, and biotechnology firms. With a focus on data quality and technical expertise, Novogene facilitates large-scale genomic studies and precision medicine initiatives through its network of high-capacity laboratories and integrated data management systems.

Recent filings

Filing Released Lang Actions
诺禾致源关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Beijing Nuohua Zhiyuan Technology Co., Ltd. regarding a change in accounting policy related to the adoption of a new lease accounting standard issued by the Ministry of Finance of China. It explains the reasons for the change, the effective date, and the expected impact on the company's financial statements. The document is relatively short (1392 characters) and does not contain actual financial statements or detailed financial data. It is a formal disclosure about an accounting policy change rather than a full audit report or annual report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements and compliance disclosures that do not fit other specific categories.
2021-04-26 Chinese
诺禾致源2021年第一季度报告正文
Interim / Quarterly Report Classification · 95% confidence The document is titled '2021 年第一季度报告' which translates to '2021 First Quarter Report'. It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and explanations of financial changes for the quarter ending March 31, 2021. The document is over 6000 characters, indicating it is a full report rather than a brief announcement. It explicitly states it is a quarterly report and includes comprehensive financial data and analysis for the quarter, which fits the definition of an Interim / Quarterly Report (IR). There is no indication that this is an announcement of a report or a certification document, so it is not RPA or RNS. Therefore, the correct classification is IR with high confidence. Q1 2021
2021-04-26 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the Articles of Association (章程) of Beijing Novogene Co., Ltd. It contains detailed chapters on company organization, shareholder rights, board of directors, management, financial accounting, shareholder meetings, and other governance matters. It references Chinese company law, securities law, and stock exchange rules. The content is a comprehensive governance document outlining the internal rules, structure, and procedures of the company rather than a financial report or announcement. It is not an annual report, earnings release, or any other financial statement. It is not a notice or announcement but a formal governance charter. Therefore, the document best fits the category of Governance Information (CGR).
2021-04-11 Chinese
诺禾致源首次公开发行股票科创板上市公告书
Regulatory Filings Classification · 95% confidence The document is titled as a "首次公开发行股票科创板上市公告书" which translates to "Initial Public Offering (IPO) Listing Announcement on the Science and Technology Innovation Board." It contains detailed information about the company's stock listing, including stock code, listing date, shareholding structure, risk factors, and regulatory approvals from the China Securities Regulatory Commission and Shanghai Stock Exchange. The document is lengthy (15,000 characters) and provides comprehensive details about the IPO and listing process, but it is not a financial report like an annual or quarterly report. It is an official announcement related to the company's stock listing event. Therefore, the document fits best into the category of Regulatory Filings (RNS) as it is a regulatory announcement about the IPO and listing, not a financial report or earnings release.
2021-04-11 Chinese
诺禾致源首次公开发行股票并在科创板上市招股说明书
Share Issue/Capital Change Classification · 100% confidence The document is a detailed prospectus for the initial public offering (IPO) of Beijing Novogene Co., Ltd. on the Shanghai Stock Exchange's STAR Market (科创板). It includes extensive information about the company's business, risk factors, financial data, management, governance, and other disclosures typical of an IPO prospectus. The text references the issuance of new shares, share allocation, underwriting, and regulatory compliance statements. This type of document is a formal offering document used to inform investors about the company and the stock issuance. According to the filing definitions, this corresponds to a Share Issue/Capital Change (SHA) filing, which covers announcements regarding new share issues and capital changes. The document is not an annual report, earnings release, or other report types, but specifically an IPO prospectus related to share issuance and listing.
2021-04-06 Chinese
诺禾致源首次公开发行股票并在科创板上市发行结果公告
Capital/Financing Update Classification · 95% confidence The document is titled as an "发行结果公告" which translates to "Issuance Results Announcement" for the company's initial public offering (IPO) and listing on the STAR Market (科创板). It details the issuance price, number of shares issued, subscription results for strategic investors, online and offline investors, and the lottery results for offline allotment. It also includes information about underwriting and contact details for the sponsor. The document is a formal announcement of the results of a capital raising event (IPO) rather than a financial report or regulatory filing about ongoing operations or financial performance. It does not contain financial statements or management discussion but focuses on the issuance and subscription results of new shares. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), indicating it is not a brief notice or a simple report publication announcement. Confidence is high due to the clear focus on share issuance and subscription results.
2021-04-06 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.